Evidence map›Paper›PMID 29678193›Full record

ArticleTrials2018

Treating prolonged grief disorder with prolonged grief-specific cognitive behavioral therapy: study protocol for a randomized controlled trial.

Rita Rosner, Eline Rimane, Anna Vogel, Jörn Rau, Maria Hagl

Abstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review of Grief Therapies for Older Adults.Current geriatrics reports · 2021
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rita RosnerDepartment of Psychology, Catholic University Eichstätt-Ingolstadt, Ostenstr. 26, 85071, Eichstätt, Germany. rita.rosner@ku.de.
Eline RimaneDepartment of Psychology, Catholic University Eichstätt-Ingolstadt, Ostenstr. 26, 85071, Eichstätt, Germany.ORCID http://orcid.org/0000-0003-0983-0118
Anna VogelDepartment of Psychology, Catholic University Eichstätt-Ingolstadt, Ostenstr. 26, 85071, Eichstätt, Germany.
Jörn RauCoordinating Center for Clinical Trials of the Philipps University of Marburg, Karl-von-Frisch-Straße 4, D-35043, Marburg, Germany.
Maria HaglDepartment of Psychology, Catholic University Eichstätt-Ingolstadt, Ostenstr. 26, 85071, Eichstätt, Germany.

Funding

Deutsche Forschungsgemeinschaft RO 2042/7-1
6 · The paper itself

Abstract

backgroundProlonged grief disorder (PGD) has emerged as a well-defined and relatively common mental disorder that will be included in the upcoming revision of the International Classification of Diseases. Recent trials with grief-specific, mostly cognitive behavioral interventions for patients with a clinically relevant diagnosis of PGD showed large effect sizes. However, a small trial suggested that non-specific behavioral activation might suffice to improve PGD. So, more evidence for the relative efficacy of grief-specific treatments is needed, as is more research on the predictors of treatment success. The purpose of the proposed trial is to evaluate a newly developed and successfully pilot-tested, prolonged grief-specific, integrative cognitive behavioral therapy (PG-CBT) compared to an active yet unspecific treatment, present-centered therapy (PCT).

methodsIn a multicenter, randomized controlled trial with 204 adults with a primary diagnosis of PGD, PG-CBT is compared to PCT, assuming the superiority of PG-CBT. Both treatments consist of 20 to 24 individual sessions, with an overall treatment length of about 6 months. The primary outcome, grief symptom severity, is assessed by blinded interviewers 12 months after randomization. Secondary outcomes are grief symptom severity at post treatment, in addition to self-reported overall mental health symptoms, depressive and somatoform symptoms at post treatment and 12 months post randomization. Possible moderators and mediators of treatment success are also explored. DISCUSSION: The trial is designed to avoid bias as much as possible (stratified randomization performed independently, blinded outcome assessment, intention-to-treat-analysis, balanced treatment dose, continuous supervision, control for allegiance effects) thereby enhancing internal validity. At the same time, some aspects of the trial will ensure clinical relevance (recruiting at outpatient clinics that are part of routine health care and keeping exclusion criteria to a minimum). Since the trial is powered adequately for the primary outcome, all secondary analyses including moderator analyses are exploratory by nature. The results will extend the knowledge on efficacious treatment of PGD and its predictors.

trial registrationGerman Clinical Trials Register, ID: DRKS00012317 . Registered on 6 September 2017.

Indexed as

Cognitive Behavioral TherapyGriefAdolescentAdultAgedFemaleGermanyHumansMaleMental DisordersMental HealthMiddle AgedMulticenter Studies as TopicRandomized Controlled Trials as TopicSeverity of Illness IndexTime FactorsAdultsComplicated griefIntegrative cognitive behavioral therapyPresent-centered therapyProlonged grief disorderRandomized controlled trial

Identifiers

PMID29678193
PMCPMC5910599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.